Sudarshan Pharma Industries Secures GMP and ISO 9001:2015 Certifications for Hyderabad Facility, Strengthening Global Quality Credentials

Mumbai (Maharashtra) [India], February 19: Sudarshan Pharma Industries Limited has announced that it has successfully obtained two significant international certifications for its manufacturing facility located in Hyderabad, Telangana. The company has been awarded Good Manufacturing Practice (GMP) compliance certification by UK Certification & Inspection Limited and ISO 9001:2015 Quality Management System certification from Staunchly Management and System Services Private Limited, reinforcing its commitment to maintaining global manufacturing and quality standards.

The certifications apply to the facility's operations related to the manufacturing of active pharmaceutical ingredient (API) intermediates and APIs. Both approvals are valid until February 11, 2029, subject to periodic surveillance audits, underscoring sustained compliance with internationally recognized regulatory and quality benchmarks. These recognitions affirm that the plant operates under stringent systems designed to ensure consistency, safety, and efficiency in production processes.

Commenting on the achievement, the company's leadership noted that securing these certifications represents a significant milestone in Sudarshan Pharma's growth journey. The recognition highlights the company's focus on robust manufacturing practices, continuous process improvement, and adherence to globally accepted quality frameworks.

The certifications are expected to further enhance Sudarshan Pharma's positioning as a reliable and compliant manufacturer in the API and pharmaceutical intermediates segment. By aligning its operations with international standards, the company aims to strengthen stakeholder confidence, expand global business opportunities, and reinforce its reputation as a quality-driven pharmaceutical manufacturer.

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor